dacarbazine has been researched along with Hypomelanosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfano, R; Argenziano, G; Conforti, C; Corneli, P; Piccolo, V; Russo, T; Zalaudek, I | 1 |
| Bhawan, J; Demierre, MF; Karakis, I; McGeeney, B; Thiele, JJ; Wolpowitz, D | 1 |
2 other study(ies) available for dacarbazine and Hypomelanosis
| Article | Year |
|---|---|
Mees' lines because of chemotherapy for Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hypopigmentation; Male; Nail Diseases; Vinblastine; Young Adult | 2020 |
Acquired hypopigmentation (leukoderma) as a presenting feature of metastatic amelanotic melanoma with brain involvement.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Dexamethasone; Humans; Hypopigmentation; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Melanoma, Amelanotic; Middle Aged; Neurologic Examination; Skin Neoplasms; Temozolomide | 2007 |